Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant

This study presents the case of a late clinical leaflet thrombosis 1.5 years after percutaneous aortic valve replacement, despite adequate non-vitamin K anticoagulant therapy. Optimal antithrombotic therapy after transcatheter aortic valve replacement remains undetermined. After switching to vitamin...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmeliet, Tom, Vermeersch, Paul, Prihadi, Edgard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387837/
https://www.ncbi.nlm.nih.gov/pubmed/34471877
http://dx.doi.org/10.1016/j.jaccas.2021.06.012
_version_ 1783742526084087808
author Carmeliet, Tom
Vermeersch, Paul
Prihadi, Edgard A.
author_facet Carmeliet, Tom
Vermeersch, Paul
Prihadi, Edgard A.
author_sort Carmeliet, Tom
collection PubMed
description This study presents the case of a late clinical leaflet thrombosis 1.5 years after percutaneous aortic valve replacement, despite adequate non-vitamin K anticoagulant therapy. Optimal antithrombotic therapy after transcatheter aortic valve replacement remains undetermined. After switching to vitamin K antagonist therapy, complete resolution occurred at 3 months follow-up. (Level of Difficulty: Intermediate.)
format Online
Article
Text
id pubmed-8387837
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83878372021-08-31 Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant Carmeliet, Tom Vermeersch, Paul Prihadi, Edgard A. JACC Case Rep Case Report This study presents the case of a late clinical leaflet thrombosis 1.5 years after percutaneous aortic valve replacement, despite adequate non-vitamin K anticoagulant therapy. Optimal antithrombotic therapy after transcatheter aortic valve replacement remains undetermined. After switching to vitamin K antagonist therapy, complete resolution occurred at 3 months follow-up. (Level of Difficulty: Intermediate.) Elsevier 2021-08-19 /pmc/articles/PMC8387837/ /pubmed/34471877 http://dx.doi.org/10.1016/j.jaccas.2021.06.012 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Carmeliet, Tom
Vermeersch, Paul
Prihadi, Edgard A.
Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant
title Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant
title_full Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant
title_fullStr Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant
title_full_unstemmed Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant
title_short Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant
title_sort late clinical valve thrombosis after transcatheter aortic valve replacement despite non-vitamin k anticoagulant
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387837/
https://www.ncbi.nlm.nih.gov/pubmed/34471877
http://dx.doi.org/10.1016/j.jaccas.2021.06.012
work_keys_str_mv AT carmeliettom lateclinicalvalvethrombosisaftertranscatheteraorticvalvereplacementdespitenonvitaminkanticoagulant
AT vermeerschpaul lateclinicalvalvethrombosisaftertranscatheteraorticvalvereplacementdespitenonvitaminkanticoagulant
AT prihadiedgarda lateclinicalvalvethrombosisaftertranscatheteraorticvalvereplacementdespitenonvitaminkanticoagulant

Ejemplares similares